喜來芝 Shilajit
B 1 C 2
適應症與證據等級
法規與權威立場 (L4)
L4a · US FDA
立場:cautious
L4b · EU EFSA
立場:neutral
Not Novel in Food Supplements (any other Food uses may be considered as Novel).
來源 ↗ L4c · UK NHS
立場:not_addressed
Check any herbal medicine has a traditional herbal registration (THR) mark and a product code from the Medicines and Healthcare products Regulatory Agency (MHRA). These will be on the medicine packaging. They show the medicine has been licensed for use in England and meets safety standards. … do not buy unlicensed herbal medicines online – they may not be safe
來源 ↗ L4d · TW TFDA / 衛福部
立場:not_addressed
(食藥署「食品原料整合查詢平臺」、邊境檢驗不符合食品資訊查詢系統、衛福部中醫藥司「可同時提供食品使用之中藥材」清單、中藥許可證查詢系統均無「喜來芝 / Shilajit / 希拉吉 / 夏拉吉特 / Asphaltum punjabianum / Mumijo」相關登錄條目。)
來源 ↗ L4e · WHO
立場:cautious
Shilajit must have undergone a purification process, and the mineral content of Shilajit must be analyzed with daily doses of minerals not exceeding the maximum daily doses as per the NNHPD Multi-Vitamin/Mineral Supplements monograph.
來源 ↗ 市場與行銷 (L10)
L10a · TW Market Channels
Havasu Nutrition, 喜來芝,60 粒膠囊 $353
L10b · TW Legal Identity (TFDA)
食品不得為醫療效能之標示、宣傳或廣告
L10c · TW Community (PTT/Dcard/Mobile01)